chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I woke up early morning and felt like someone had a hot frying pan on my lower arms, I thought they were Shingles. I had never felt the same feeling before. I swear it felt like it was going into the muscle and at one point I couldn't go to the bathroom because I was in so much pain. I was rocking myself in the couch due to the pain. I'm a phycologist so I was doing all the research and I decided to contact my doctors and they were not so concerned. I felt like I was sick with Flu at level 10, I couldn't walk up and down the steps and my mind couldn't coordinate my steps all the time. I tried walking my dogs and that was even hard. I'm used to running 10K so I tried but It felt like I was going to be like this for ever and about 3 weeks after my vaccination I started feeling okay. The coordination un my body lasted about 3 days. I have seen 3 different doctors because I was concerned with any neurological issues. They couldn't really do anything to treat me. I have contacted my doctor because  I'm not sure about the second vaccine. I got in contact with public health, my doctors got in contact with public health and they pretty much said It was up to me but that they prescribed Prednisone in case I had a worse reaction and to help the inflammatory in my body.  after 3 weeks I was feeling normal so I made the decision to take the second vaccine at that point. Mentally I was pissed because the social media was posting of how it only gives you a sore arm. That wasn't my case.
Information has been received from a physician assistant concerning a 15 year old "healthy individual" female who on approximately 23-FEB-2007, was vaccinated with Gardasil first dose. On approximately 23-FEB-2007 (also reported as about a week after Gardasil was administered, the patient experienced swelling and hives in her extremities area. The reporting physician assistant does not treat this patient and did not want to be contacted. The treating physician works in the same office as the reporter but also did not want to contacted as the physician did not feel the events were related. No lab or diagnostic tests were performed. Unspecified medical attention was sought. As of 02-MAR-2007, the patient's swelling and hives in her extremities persisted. No further information is available.
G62.9 NEUROPATHY 11/7/2022 BACK PAIN G62.9 NEUROPATHY 11/7/2022 CANCER METASTATIC TO BONE G62.9 NEUROPATHY 11/7/2022 CANCER METASTATIC TO BONE
3 days after vaccine, started chest pain which also spread to shoulder. It felt like tightly squeezing the arm.
Sore throat and minor aches.  Feeling feverish. Extreme fatigue. Slept for nearly 24 hours.  Mild headache
Information has been received from the authors of the literature article. The aim of this study was to evaluate persistence of varicella (VZV) specific antibodies after vaccination with 1 or 2 doses of VZV vaccine (manufacturer unknown) and to identify determinants of varicella seropositivity in a large cohort of children and adolescents with PHIV and also in perinatally HIV-exposed but uninfected (PHEU) children. The Adolescent Master Protocol (AMP), a component of the Pediatric HIV/AIDS Cohort Study, is an ongoing prospective cohort study designed to evaluate long-term effects of HIV infection and antiretroviral therapy (ART) among children with PHIV, It enrolled 451 children with PHIV and 227 PHEU children aged 7-16 years from March 2007 to November 2009 at 15 sites. Participants were required to have  complete medical history of ART use, plasma HIV RNA concentrations, and lymphocyte subset measurements since birth. There were 653 subjects (432 PHIV and 221 PHEU) whose birth years ranged from 1991 to 2002. Compared with PHEU subjects, more subjects with PHIV were living in poverty. At the time their specimens were obtained for testing, subjects with PHIV were older and had a lower BMI z score than PHEU subjects. Overall, fewer subjects with PHIV compared with PHEU subjects received VZV vaccine, with 38% vs 18% unvaccinated, 26% vs 25% having received 1 dose, and 34% vs 55% having received 2 doses, respectively (P<.001). Subjects  with PHIV were older than PHEU subjects at the time of their first vaccine (median: 4.7 vs 1.5 years; P < .001), had a shorter interval between first and second vaccinations (median: 3.9 vs 6.1 years; P < .001), and had more documented HZ episodes (10% vs 0%; P < .001). The median interval from last vaccine dose to sample collection was longer for subjects with PHIV than PHEU subjects (4.2 vs 3.5 years; P< .05). Of the 653 subjects tested, 84 (24.8%) tested negative by wcELISA. Among those testing negative, 78 (11.9% of all subjects) then tested positive by gpELISA. Overall, 87% of the cohort was seropositive to varicella, with a seroprevalence among subjects with PHIV of 82% (95% Cl, 78%-86%), significantly lower than among PHEU subjects (97%; 95%Cl, 94%-99%). This case concerns of 2 patient who received >/= 3 doses of VZV vaccine (manufacturer unknown) in the PHIV cohort, and were seronegative. This is one of several reports from the same literature source (linked to MARRS # 1602USA002825 and 1602USA004825). Additional information has been requested.
Pt. stated on 12/20/16 left arm hurt during the night had significant itching and swelling. Had temp. 101 F and Mom gave ADVIL. On 12/21/16 office visit progressing upper arm lightly erythematous, mildly indurated, non tender, child is scratching during visit. Meds - Betamethasone cream, BENADRYL 2.
I have been on chemo since April 2015 and Double Chemo since April 2017 and am currently still on treatment.  In the years I have been on chemo and I also have an IUD in my uterus (because you can't get pregnant on chemo) I have not had a menstrual cycle in almost 6 years.  After getting my second Moderna shot I had a full blown period/menstrual cycle for 2 whole days (48 hours).  Got the Moderna shot Friday morning and then the menstrual cycle started less than 12 hours later and lasted for two days. There was cramping, heavy flow, bright red blood like how they use to be before chemo.  My Oncologist and My OB/GYN  encouraged me to report this side effect of the Moderna to the CDC
Pink/red rash around neck, in cleavage, on stomach; does not itch or hurt
Bell's palsy; This is a spontaneous report from a contactable consumer.   A 67-year-old male patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration, administered in left arm on 03Mar2021 17:00 (Batch/Lot Number: EL9266), at the age of 67-years at vaccination, as SINGLE DOSE for covid-19 immunisation.  Medical history included ongoing blood pressure high has had for about 2-3 years. Concomitant medications included amlodipine 10mg once daily taken for hypertension, start and stop date were not reported.  The patient got Bell's palsy on 12Mar2021 in the evening. States that he saw his doctor on 18Mar2021, and the doctor didn't have a problem with him getting his 2nd dose, which is scheduled on 23Mar2021. She is assuming it's okay for him to get the 2nd one. The outcome of the event was not recovered.
A health professional reported the occurrence of limb swelling in a 4 year old subject of unspecified gender who was vaccinated with diphtheria and tetanus toxoids and acellular pertussis vaccine absorbed for prophylaxis. The subject's medical history, concurrent conditions, and concurrent medications were not reported. On an unspecified date in May 2003, the subject received the fifth injection of Infanrix (lot DTPA586A9). Subsequently, the subject developed hugely abnormal limb swelling. The subject was seen by the physician. The reporter considered the limb swelling to be possibly related to Infanrix administration. As of 5/15/03, the event persisted. Comment: The reporter indicated that three 4 year old children developed limb swelling following receipt of Infanrix lot DTPA586A9. However, they are not presently identifiable.
Joint pain; Tennis elbow; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot number: EL6199), via an unspecified route of administration in the right arm on 04Mar2021 at 17:00 (at the age of 34-years-old), as a single dose for COVID-19 immunisation. The patient had no medical history. The patient did not have any allergies to medications, food or other products. The patient did not take any concomitant medications. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL9269), via an unspecified route of administration in the left arm on 10Feb2021 at 17:00 (at the age of 34-years-old), as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 05Mar2021, the patient experienced joint pain in many joints that dissipated. The pain was dissipated in all joints within a week except in left elbow. The left elbow had exacerbated into tennis elbow. It was still hurting as of the end of March. The adverse events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. The patient did not receive any treatment for the adverse events. The clinical outcome of join pain and tennis elbow were not recovered at the time of reporting.   No follow-up attempts are needed. No further information is expected.
Left arm large golf ball size knot, tender, red, itchy, stiffness in arm
Fever 102 lasted for 3 days; nasal congestion for 3 days.
Headache; This case was reported by a consumer via call center representative and described the occurrence of headache in a 77-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 10th January 2023, the patient received the 2nd dose of Shingrix (intramuscular). On 11th January 2023, 1 days after receiving Shingrix, the patient experienced headache. The patient was treated with paracetamol (Acetaminophen). On an unknown date, the outcome of the headache was not recovered/not resolved.   It was unknown if the reporter considered the headache to be related to Shingrix.     Additional Information: GSK receipt date: 11-JAN-2023 Reporter's comment:  The reporter was patient's wife. The reporter reported that she and her husband received their 2nd Shingrix dose yesterday. THe patient experienced headache 6 hours after the vaccination.  The patient woke in the night with a headache unresolved by acetaminophen.  The reporter did not consent to follow-up.
I had coughs and sinus issues with no fever. I was extremely tired and loss my sense of taste and smell for 3 to 4 days. I tested for COVID-19 on 10/15/2022 and I contacted my doctor's office and the COVID team contacted me and prescribed an oral medication to treat the symptoms. I am not sure which medication was prescribed. My symptoms improved after about a week. The cough dragged on afterwards. It eventually resolved and I completely recovered from my symptoms.
Approximately 20 hours after vaccine patient presented severe vomiting followed by severe diarrhea until approximately 9:00 p.m. on 10/3/2018. Was given Gatorade and applesauce to try to curb dehydration.
pt recv vax; large reddened area covering entire lt upper arm; weeping blister at site; n & v; chills & fever;
This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. There was no information about patient's concomitant medications and pertinent medical history reported. On 11-DEC-2015, the patient was vaccinated with a dose of PNEUMOVAX 23 lot # J013555, expiry date 02-MAY-2015 (dose, route and site of administration were not reported). No adverse effects were reported. Additional information has been requested.
Severe chills; body aches; Low fever; Migraine; This is a spontaneous report from a contactable Consumer. This 48-Year-old Female Consumer (patient) reported A 48-years-old non-pregnant female patient (not pregnant at the time of vaccination) received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: EN6202), via an unspecified route of administration, administered in Left arm on 09Mar2021 14:45 (at the age of 48-years-old) as dose 1, single for covid-19 immunisation. The patient medical history included hypothyroidism from an unknown date and unknown if ongoing, Iron Deficiency woyh Anemia from an unknown date and unknown if ongoing. The patient had no known allergies. The patient concomitant medications included levothyroxine sodium (SYNTHROID) taken for an unspecified indication, start and stop date were not reported, liothyronine (LIOTHYRONINE) taken for an unspecified indication, start and stop date were not reported, escitalopram (ESCITALOPRAM) taken for an unspecified indication, start and stop date were not reported and melatonin (MELATONIN) taken for an unspecified indication, start and stop date were not reported. The patient had not taken other vaccine in four weeks. The patient had not been tested for covid, prior vaccination. The patient had been tested for covid, post vaccination. On an unspecified date on Mar2021, the patient experienced Severe chills and body aches, Low fever and Migraine. Low fever, Migraine that does not respond to pain medication. The patient not received treatment for events severe chills and body aches. The events resulted in Emergency/urgent care visit. The patient underwent lab tests and procedures which included sars-cov-2 test (nasal swab) negative, on 15Mar2021. The clinical outcome of the events was not recovered.  No follow-up attempts are possible. No further information is expected.
pt received the IMZ at 11:59am. instructed wait time 12:15pm in the designated chair provided. at 12:08pm she came up to the counter. As i came around the corner, I saw she was pale. she then fainted and I ran out the door.  a male customer caught her and eased her to the floor. i knelt beside her checking pulse and respirations. both WNL. after 10 seconds she came to with extreme sweating. i removed BOTH masks and pull her long hair away from her face to cool her off. got a cool wet paper towel and put on her forehead. i had her raise her legs against the wall to elevate.  her mom came in and said as a kid she fainted often due to a vasovagal overstimulation. her mom helped her to the chair and sat for a few more minutes. leaving at 12:20pm with her mom.
Nagging cough that went away after a week or so,  waves of fatigue every few hours I cannot fight that force me to lay down and sleep
Redness, rash inside of left arm; sensitive and warm to the touch. 10/18/14 pt states he is feeling better and redness and swelling had gone down.
9/11: Patient felt tired and had low grade fever of 100.3.  9/12: Patient still felt tired and had low grade fevers. 9/13: Around 10pm, as patient was going to sleep, patient started to complain of chest pain described as sharp and midsternal. The patient rates the pain a 7/10 and states its nonradiating. The pain lasted 30-40 minutes and then self resolved and patient went to the ED.  9/13,ED: Troponin noted to be elevated. Patient given Ibuprofen 386 mg. CXR and EKG were done. CBC, CK and blood culture obtained. Patient was admitted.  9/14: Upon admission, Patient was started on Ibuprofen 400 mg q6 and Pepcid 20mg BID. Serial EKG and troponins were obtained. Patient was evaluated by cardiology. Echocardiogram was obtained.   9/15: Patient was evaluated by infectious disease. Labs were sent including lyme serology, EBV and CMV studies and Enterovirus PCR. Patient was cleared for discharge and outpatient follow up with cardiology and infectious disease. Patient discharged on Ibuprofen q8 and Pepcid 20mg BID for 2 weeks until they follow up with cardiology. Patient instructed to refrain from all strenuous physical activity and gym and to only participate in ADLs.
local rx onset 36hr p/inj w/redness, heat, induration 8x9cm-no distance;
Significant reaction (12x7 cm) oval red, indurated reaction to PREVNAR 13 vaccine, properly administered.
sore throat; experiencing headache; This case was received via Agency Regulatory Authority (Reference number: US-irms-MOD21-126158) on 03-Aug-2021 and was forwarded to Moderna on 03-Aug-2021.    This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (sore throat) and HEADACHE (experiencing headache) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. UNK) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced OROPHARYNGEAL PAIN (sore throat) and HEADACHE (experiencing headache). At the time of the report, OROPHARYNGEAL PAIN (sore throat) and HEADACHE (experiencing headache) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication information was provided by the reporter. No treatment information was provided by the reporter.
COVID 19 Treatment/ continued to test positive over four days; COVID 19 Treatment/ continued to test positive over four days; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 68-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), in Aug2021 as dose 2 (booster), single (Batch/Lot number: unknown) at the age of 67 years, in left arm for covid-19 immunisation; coviD-19 vaccine mrna (mrna 1273) (MODERNA COVID-19 VACCINE), on 08Jan2022 as dose 3 (booster), single (Lot number: LGH022887060), in left arm for covid-19 immunisation; janssen coviD-19 vaccine (JANSSEN COVID-19 VACCINE), on 06Mar2021 as dose 1, single (Lot number: 1805022), in left arm for covid-19 immunisation. The patient's relevant medical history included: "mild occasional asthma" (unspecified if ongoing), notes: mild occasional asthma; "Johnson & Johnson/ Pfizer/ Moderna" (unspecified if ongoing), notes: Johnson & Johnson/ Pfizer/ Moderna. There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 25Apr2022, outcome "recovering" and all described as "COVID 19 Treatment/ continued to test positive over four days". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: negative; positive, notes: test positive over four days; negative, notes: tested negative today (5th day). Therapeutic measures were taken as a result of covid-19. Additional information- It was reported that the patient had previously receive a COVID-19 Vaccine and Five days after completing a five day treatment w paxlovid, and all symptoms disappearing and testing negative, symptoms reappeared and I tested positive. I continued to test positive over four days and finally tested negative today (5th day)  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
patient used to get the flu shot and every single year was ill with the flu shortly afterward; Initial information received on 08-Oct-2020 regarding an unsolicited valid non-serious case from a consumer via social media.  This case involves an unknown age patient who got ill with flu shortly afterward (influenza), after receiving INFLUENZA VACCINE.  The patient's past vaccination(s) included flu shot and the only years patient succumbed to the flu was when received a vaccine.  Medical history, medical treatment(s), concomitant medication(s) and family history were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiration date not reported) via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date, the patient got ill with the flu shortly afterward (influenza) (non-serious) (unknown latency) following the administration of INFLUENZA VACCINE. patient also reported that was not sick immediately after the shot.  No laboratory data reported.  It was not reported if the patient received a corrective treatment.  At the time of reporting, the outcome was not reported for the reported event.  Follow up information was received on 08-Oct-2020 from a consumer via social media.  Narrative description was added.
Patient did not receive childhood vaccinations due to siblings adverse reactions to vaccines. Patient met with provider, who coordinated with Immunization Coordinator and to come up with vaccine schedule for patient to get vaccines pt needed. Pt was receiving one vaccine every 2 weeks and pt was observed for 30 minutes post injection. Pt received first dose  of MMR on 10/05/23. No symptoms 30 minutes after injection of vaccine. Pt came back to office to receive first dose of Hep B vaccine on 10/17/23. At this time patient was asked if she had any signs or symptoms of illness, pt verbalized she did not. Pt sent in encounter on 10/18/23 stating that on 10/16/23 she developed lymphadenopathy and a headache. After receiving first Hep. B vaccine in 10/17/23 pt developed a pruritic rash on chest, face, and arms, fever, arthralgias, mild rhinorrhea.
Moderna    First Injection                   Woke up with very strong charlie horse like pain in both lower calves.                                                                             Was extremely hot knot without touching.       Stood slowly and walked off.  Due to Vaccine?   Or standing in very cold temps for two hours prior to receiving  F IRST injection?
The of receiving vax, pt developed redness at the injection site. The area of redness measured 3-4" in diameter. No addtl information was available as of the date of this report. Manufacturer's Comment: This pt is 1 of 2 patients who experienced this event following receipt of Prevnar lot 479-792. The reported indicated that 3 pts experienced this event; however, 1 is not presently identifiable. An addtl report will be generated when identifying info is provided.